<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001578771</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001496323</issuerCik>
      <issuerName>IGM Biosciences, Inc.</issuerName>
      <secFileNumber>001-39045</secFileNumber>
      <issuerAddress>
        <com:street1>325 E MIDDLEFIELD ROAD</com:street1>
        <com:city>MOUNTAIN VIEW</com:city>
        <com:stateOrCountry>CA</com:stateOrCountry>
        <com:zipCode>94043</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>650-965-7873</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Hambleton Julie</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Director</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Wells Fargo Advisors</name>
        <address>
          <com:street1>One North Jefferson Avenue</com:street1>
          <com:city>St. Louis</com:city>
          <com:stateOrCountry>MO</com:stateOrCountry>
          <com:zipCode>63103</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>15132</noOfUnitsSold>
      <aggregateMarketValue>211078.51</aggregateMarketValue>
      <noOfUnitsOutstanding>33636592</noOfUnitsOutstanding>
      <approxSaleDate>07/25/2024</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>07/25/2024</acquiredDate>
      <natureOfAcquisitionTransaction>Stock Options</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>15132</amountOfSecuritiesAcquired>
      <paymentDate>07/25/2024</paymentDate>
      <natureOfPayment>Wire</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>07/25/2024</noticeDate>
      <planAdoptionDates>
        <planAdoptionDate>03/14/2024</planAdoptionDate>
      </planAdoptionDates>
      <signature>Julie Hambleton</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
[{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 2819}]
144
0001578771
XXXXXXXX
LIVE
0001496323
IGM Biosciences, Inc.
001-39045
325 E MIDDLEFIELD ROAD
MOUNTAIN VIEW
CA
94043
650-965-7873
Hambleton Julie
Director
Common
Wells Fargo Advisors
One North Jefferson Avenue
St. Louis
MO
63103
15132
211078.51
33636592
07/25/2024
NASDAQ
Common
07/25/2024
Stock Options
Issuer
N
15132
07/25/2024
Wire
Y
07/25/2024
03/14/2024
Julie Hambleton